TMED vs. CANC
TMED (T. Rowe Price Health Care ETF) and CANC (Tema Oncology ETF) are both Health & Biotech Equities funds. At a correlation of -0.04, they often move in opposite directions. TMED charges 0.44%/yr vs 0.75%/yr for CANC.
Performance
TMED vs. CANC - Performance Comparison
Loading charts...
Returns By Period
TMED
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CANC
- 1D
- 1.64%
- 1M
- 1.56%
- YTD
- 11.49%
- 6M
- 9.19%
- 1Y
- 56.88%
- 3Y*
- 132.65%
- 5Y*
- —
- 10Y*
- —
TMED vs. CANC - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
TMED T. Rowe Price Health Care ETF | -7.14% |
CANC Tema Oncology ETF | 6.36% |
Correlation
The correlation between TMED and CANC is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 4, 2026 | -0.04 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. CANC — Risk / Return Rank
TMED
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CANC
TMED vs. CANC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMED | CANC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.40 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 6.15 | — |
| Martin ratioReturn relative to average drawdown | — | 16.71 | — |
Loading charts...
Drawdowns
TMED vs. CANC - Drawdown Comparison
The maximum TMED drawdown since its inception was -7.14%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for TMED and CANC.
Loading charts...
Drawdown Indicators
| TMED | CANC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -7.14% | -97.53% | +90.39% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.30% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -30.27% | — |
Current DrawdownCurrent decline from peak | -7.14% | -53.78% | +46.64% |
Average DrawdownAverage peak-to-trough decline | -5.00% | -72.94% | +67.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.41% | — |
Volatility
TMED vs. CANC - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | CANC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 6.60% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 16.94% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 66.28% | 22.72% | +43.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.28% | 278.65% | -212.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.28% | 278.65% | -212.37% |
TMED vs. CANC - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than CANC's 0.75% expense ratio.
Dividends
TMED vs. CANC - Dividend Comparison
TMED has not paid dividends to shareholders, while CANC's dividend yield for the trailing twelve months is around 0.05%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CANC Tema Oncology ETF | 0.05% | 0.06% | 3.00% | 0.56% |
TMED T. Rowe Price Health Care ETF | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and CANC have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.75% for CANC.
CANC has the higher dividend yield at 0.05%, compared with 0.00% for TMED.
They also come from different issuers: T. Rowe Price and Tema. Their fees differ too: 0.44% for TMED and 0.75% for CANC.
Find the right allocation for TMED and CANC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer